pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Former NIAID adviser David Morens pleads guilty to concealing records and defrauding government

Aug 18, 2026·read at STAT ↗RegulatoryNegative

David Morens, a former top National Institute of Allergy and Infectious Diseases official and longtime senior adviser to former NIAID leader Anthony Fauci, entered a guilty plea on Tuesday on charges of concealing records from Freedom of Information Act requests.

Prosecutors say Morens knowingly worked with at least one other individual to evade public disclosure requirements and to use his influence to advance the interests of a particular company.

He directed the co-conspirator to keep communications off government phones and email servers and expressed hopes of future financial support for that person.

The plea arrives amid heightened Republican scrutiny of the federal Covid-19 response and raises concerns about corporate influence within public health agencies.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Fauci adviser David Morens pleads guilty to avoiding records requests, conspiracy to defraud government”

read at STAT ↗
620 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING
topics
Infectious Disease

related stories

  • 9h agoEMD Serono cuts 20 at Massachusetts research siteBioSpace
  • Jul 15What to know about the parasitic diarrhea outbreakSTAT
  • Jul 15Opinion: Why we still don’t know what foods are the source of the cyclospora outbreakSTAT
  • Jul 8Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study saysSTAT
  • Jul 2Opinion: CDC leadership continues to try to manufacture a scientific debate on vaccines where none existsSTAT